Solventum Corp
SOLVAPI behind this page
SOLV FY 2025 request
Playground key active
/api/financials?ticker=SOLV&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue | 8,325 | 8,254 | +0.9% |
Show Product Lines breakouts |
|||
| Cost of software and rentals | 1,976 | 1,906 | +3.7% |
| Product | 6,349 | 6,348 | 0.0% |
| Product · After Spin-Off | 78 | 50 | +56.0% |
Show Business Segments breakouts |
|||
| Dental Solutions · Operating Segments | 1,349 | 1,295 | +4.2% |
| Health Information Systems · Operating Segments | 1,360 | 1,306 | +4.1% |
| MedSurg · Advanced Wound Care | 1,883 | 1,835 | +2.6% |
| MedSurg · Infection Prevention and Surgical Solutions | 2,934 | 2,802 | +4.7% |
| MedSurg · Operating Segments | 4,817 | 4,637 | +3.9% |
| Purification and Filtration · Operating Segments | 497 | 709 | -29.9% |
Show Geography breakouts |
|||
| Non Us | 3,657 | 3,695 | -1.0% |
| US | 4,668 | 4,559 | +2.4% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 302 | 306 | -1.3% |
| Operating Segments | 7,526 | 7,238 | +4.0% |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | 78 | 50 | +56.0% |
| Cost of Revenue (FY) | — | — | — |
Show Product Lines breakouts |
|||
| Cost of software and rentals | 472 | 489 | -3.5% |
| Product | 3,402 | 3,172 | +7.3% |
| Product · After Spin-Off | 616 | 357 | +72.5% |
Show Related Party Transaction breakouts |
|||
| Master Supply Agreements · Related Party | 241 | 128 | +88.3% |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | 58 | 37 | +56.8% |
| Gross Profit | 4,451 | 4,593 | -3.1% |
| Selling, General & Administrative | 3,080 | 2,782 | +10.7% |
Show Related Party Transaction breakouts |
|||
| After Spin-Off · Related Party | 249 | 202 | +23.3% |
| Research & Development | 739 | 775 | -4.6% |
Show Related Party Transaction breakouts |
|||
| After Spin-Off · Related Party | 11 | 8 | +37.5% |
| Gain Loss On Sale Of Business | -1,549 | — | — |
| Operating Income | 2,181 | 1,036 | +110.5% |
Show Business Segments breakouts |
|||
| Dental Solutions · Operating Segments | 346 | 350 | -1.1% |
| Health Information Systems · Operating Segments | 496 | 431 | +15.1% |
| MedSurg · Operating Segments | 810 | 887 | -8.7% |
| Purification and Filtration · Operating Segments | 96 | 74 | +29.7% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 42 | 30 | +40.0% |
| Operating Segments | 1,652 | 1,668 | -1.0% |
| Interest Income Expense Nonoperating Net | 347 | 367 | -5.4% |
| Gains Losses On Extinguishment Of Debt | 82 | — | — |
Show Long-Term Debt Type breakouts |
|||
| Senior Notes | 94 | — | — |
| Other Non-Operating Income (Expense) | 39 | 64 | -39.1% |
| Income Before Taxes | 1,713 | 605 | +183.1% |
| Income Tax Expense (Benefit) | 157 | 127 | +23.6% |
| Net Income | 1,556 | 479 | +224.8% |
Show Equity Components breakouts |
|||
| Retained Earnings | 1,556 | 242 | +543.0% |
| EPS (Basic) | 8.94 | 2.77 | +222.7% |
| EPS (Diluted) | 8.88 | 2.76 | +221.7% |
| Wtd Avg Shares (Basic) | 174.1 | 173.2 | +0.5% |
| Wtd Avg Shares (Diluted) | 175.3 | 173.7 | +0.9% |
| Cost of Revenue (FY) | — | — | — |
Show Business Segments breakouts |
|||
| Dental Solutions · Operating Segments | 475 | 425 | +11.8% |
| Health Information Systems · Operating Segments | 341 | 361 | -5.5% |
| MedSurg · Operating Segments | 2,408 | 2,151 | +11.9% |
| Total Costs & Expenses (FY) | — | — | — |
Show Related Party Transaction breakouts |
|||
| Transition Agreement Services · Related Party | 534 | 369 | +44.7% |
| Operating Expenses (FY) | — | — | — |
Show Business Segments breakouts |
|||
| Dental Solutions · Operating Segments | 528 | 519 | +1.7% |
| Health Information Systems · Operating Segments | 523 | 513 | +1.9% |
| MedSurg · Operating Segments | 1,598 | 1,600 | -0.1% |
| Comprehensive Income | 1,986 | 291 | +582.5% |
| Other Comprehensive Income | 430 | -188 | +328.7% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | 38 | -5 | +860.0% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | -28 | 20 | -240.0% |
| Accumulated Other Comprehensive Income | 430 | -188 | +328.7% |
| Accumulated Translation Adjustment | 420 | -203 | +306.9% |
| Operating Lease Lease Income | 615 | 600 | +2.5% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 878 | 762 | +15.2% |
| Accounts Receivable | 1,034 | 1,044 | -1.0% |
| Other Receivables Net Current | 150 | 185 | -18.9% |
| Inventory Finished Goods Net Of Reserves | 636 | 539 | +18.0% |
| Inventory Work In Process Net Of Reserves | 201 | 190 | +5.8% |
| Inventory Raw Materials And Supplies Net Of Reserves | 229 | 236 | -3.0% |
| Inventory | 1,066 | 965 | +10.5% |
| Other Assets Current | 731 | 293 | +149.5% |
| Total Current Assets | 3,859 | 3,249 | +18.8% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 1,326 | 1,622 | -18.2% |
| Goodwill | 5,704 | 6,377 | -10.6% |
Show Business Segments breakouts |
|||
| Dental Solutions · Operating Segments | 477 | 439 | +8.7% |
| Health Information Systems · Operating Segments | 873 | 871 | +0.2% |
| MedSurg · Operating Segments | 4,246 | 3,597 | +18.0% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 108 | — | — |
| Other Non-Current Assets | 814 | 665 | +22.4% |
| Total Assets | 14,294 | 14,457 | -1.1% |
| Operating Lease Right-of-Use Assets | 214 | 176 | +21.6% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 2,592 | 2,544 | +1.9% |
| Current Liabilities | |||
| Accounts Payable | 687 | 618 | +11.2% |
| Accrued Liabilities | 435 | 272 | +59.9% |
| Deferred Revenue (Current) | 621 | 572 | +8.6% |
| Other Liabilities Current | 1,393 | 1,041 | +33.8% |
| Total Current Liabilities | 3,136 | 2,703 | +16.0% |
| Non-Current Liabilities | |||
| Long-Term Debt | 5,035 | 7,810 | -35.5% |
| Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent | 363 | 350 | +3.7% |
Show Retirement Plan Type breakouts |
|||
| Other Postretirement Benefit Plans Defined Benefit | 123 | 117 | +5.1% |
| Pension Plans Defined Benefit · Foreign Plan | 107 | 155 | -31.0% |
| Pension Plans Defined Benefit · US | 125 | 70 | +78.6% |
| Deferred Tax Liabilities | 164 | 225 | -27.1% |
| Other Non-Current Liabilities | 547 | 410 | +33.4% |
| Total Liabilities | 9,245 | 11,498 | -19.6% |
| Long-Term Debt | 5,035 | 8,010 | -37.1% |
Show Debt Instrument breakouts |
|||
| 5.40% Senior Notes Due 2029 · Senior Notes | 698 | 1,487 | -53.1% |
| 5.45% Senior Notes Due 2027 · Senior Notes | 349 | 995 | -64.9% |
| 5.45% Senior Notes Due 2031 · Senior Notes | 991 | 990 | +0.1% |
| 5.60% Senior Notes Due 2034 · Senior Notes | 1,636 | 1,636 | 0.0% |
| 5.90% Senior Notes Due 2054 · Senior Notes | 1,209 | 1,231 | -1.8% |
| 6.00% Senior Notes Due 2064 · Senior Notes | 42 | 492 | -91.5% |
| Credit Facilities · Three year senior term loan credit facility | 110 | 979 | -88.8% |
| Operating Lease Liabilities | 142 | 86 | +65.1% |
| Stockholders' Equity | |||
| Common Stock | 2 | 2 | 0.0% |
| Additional Paid-In Capital | 3,876 | 3,771 | +2.8% |
| Retained Earnings | 1,797 | 242 | +642.6% |
| Accumulated Other Comprehensive Income | -625 | -1,056 | +40.8% |
| Total Stockholders' Equity | 5,049 | 2,959 | +70.6% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -488 | -526 | +7.2% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | -8 | 20 | -140.0% |
| Accumulated Other Comprehensive Income | -625 | -1,056 | +40.8% |
| Accumulated Translation Adjustment | -130 | -550 | +76.4% |
| Additional Paid In Capital | 3,876 | 3,771 | +2.8% |
| Common Stock | 2 | 2 | 0.0% |
| Retained Earnings | 1,797 | 242 | +642.6% |
| Total Liabilities & Equity | 14,294 | 14,457 | -1.1% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 489 | 555 | -11.9% |
| Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash | 62 | 34 | +82.4% |
| Stock-Based Compensation | 161 | 112 | +43.8% |
| Disposal Group Including Discontinued Operation Transaction Costs | -111 | — | — |
| Deferred Income Taxes | -120 | -155 | +22.6% |
| Change in Accounts Receivable | 34 | 43 | -20.9% |
| Increase Decrease In Due From Related Parties | 44 | 233 | -81.1% |
| Change in Inventory | -139 | -132 | -5.3% |
| Change in Accounts Payable | 104 | 266 | -60.9% |
| Increase Decrease In Due To Related Parties | -11 | -395 | +97.2% |
| Increase Decrease In Accrued Salaries | 43 | 78 | -44.9% |
| Other Operating Activities Cash Flow Statement | -194 | 67 | -389.6% |
| Net Cash from Operations | 369 | 1,185 | -68.9% |
| Investing Activities | |||
| Capital Expenditures | -379 | -380 | +0.3% |
| Payments To Acquire Businesses Net Of Cash Acquired | -696 | — | — |
| Proceeds From Divestiture Of Businesses | 3,890 | — | — |
| Other Investing Activities | -18 | — | — |
| Net Cash from Investing | 2,797 | -380 | +836.1% |
| Financing Activities | |||
| Debt Repayments | -3,070 | -300 | -923.3% |
| Payments For Proceeds From Parent | -33 | -8,251 | +99.6% |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | -33 | -8,251 | +99.6% |
| Proceeds From Payments For Other Financing Activities | 46 | 8 | +475.0% |
| Net Cash from Financing | -3,057 | -240 | -1173.8% |
| Supplemental | |||
| Income Taxes Paid | 181 | 244 | -25.8% |
| Interest Paid | 442 | 287 | +54.0% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 7 | 3 | +133.3% |
| Net Change in Cash | 116 | 568 | -79.6% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 878 | 762 | +15.2% |
Values in millions USD. Source: SEC EDGAR 10-K filing.